CTT Pharmaceutical CEO Buys 3,500 Shares

What Happened
The company's CEO made a purchase of 3,500 shares of CTT Pharmaceutical Holdings, Inc. (CTTH) in an open-market or private transaction. The reported price was $0.05 per share, for a total cash outlay of approximately $172. This was a purchase (a net buy), which is generally more informative than a sale but the dollar amount is very small.

Key Details

• Transaction date: 2026-08-31 (per the transaction record)
• Price and quantity: 3,500 shares at $0.05 per share; total ≈ $172
• Filing date / accession: Filed 2026-08-31 (Accession: 0001035422-26-000008)
• Shares owned after transaction: Not specified in the provided summary — check the full Form 4 for post-transaction holdings
• Notable footnotes: None shown in the provided data (no 10b5-1, tax-withholding, gift, or derivative notes indicated)
• Timeliness: No explicit late-filing flag provided in the excerpt; filing and transaction dates are the same (Aug 31) in this summary — verify the full Form 4 if you need confirmation on timeliness

Context
This is a very small insider purchase (about $172), so while insider buys can be a bullish signal, the size here is not material. For retail investors, note the difference between small routine purchases and larger, meaningful insider buys; check the full Form 4 for exact post-transaction holdings and any additional footnotes before drawing conclusions.